What is therapeutic apheresis?
Therapeutic apheresis is a medical procedure that selectively removes harmful substances from the blood. Unlike dialysis, which filters waste products, apheresis targets specific pathogenic components: autoantibodies, inflammatory mediators, excess lipids, or toxic proteins.
The procedure draws blood from the patient, separates it into components using centrifugal or membrane-based filtration, removes the targeted fraction, and returns the cleaned blood. A single session typically lasts two to four hours.
Forms of apheresis
There is no single apheresis procedure. The modality is selected based on clinical indication. Plasmapheresis removes and replaces plasma. Immunoadsorption selectively binds and removes specific antibodies. Lipid apheresis reduces lipoprotein(a) and LDL cholesterol. INUSpheresis targets environmental toxins and inflammatory mediators. Each has a distinct mechanism and clinical application.
Who benefits from apheresis?
Apheresis is indicated for autoimmune conditions, chronic inflammatory disorders, elevated cardiovascular risk markers, post-viral syndromes including Long COVID, and neurodegenerative conditions where circulating pathogenic factors are implicated. It is also used as a longevity intervention, reducing systemic inflammation and supporting vascular health.
The goal is not to treat symptoms. The goal is to remove the cause.
At Elysium Institute, every apheresis programme begins with a comprehensive diagnostic panel to identify the specific targets for treatment. No two protocols are the same.
